StillsNow Podcast August 2022September 06, 2022Featuring a discussion with Dr. Susan Shenoi from Seattle Childrens HospitalGenetic Testing for Autoinflammatory DiseaseSeptember 01, 2022Disease Activity Scoring in Adult-onset Still's diseaseAugust 30, 2022JAK Inhibitors in Difficult Still’s DiseaseAugust 05, 2022Not Still’s – Now What?July 29, 2022Best Labs for Still’s DiseaseJuly 27, 2022FDA Approves Canakinumab for Gout FlaresAugust 30, 2023Before You Know It (8.25.2023)August 24, 2023Mono- and Oligo- are Different (8.18.2023)August 18, 2023EULAR/ACR Guidance on Haemophagocytic Lymphohistiocytosis/Macrophage Activation SyndromeJuly 26, 2023ICYMI: LAVLI – A New Autoinflammatory DisorderJuly 06, 2023EULAR 2023 Notes from Milan (6.09.2023)June 09, 20232023 EULAR/PReS Recommendations on Still's diseaseJune 08, 2023Still's Disease Abstracts at EULAR 2023June 08, 2023EULAR 2023 Notes from MilanJune 08, 2023EULAR 2023 Day 4 RecapJune 05, 2023AOSD: Young vs. Elderly OnsetJune 01, 2023“You Can Have it All” (4.7.2023)April 07, 2023LAVLI – A New Autoinflammatory DisorderMarch 28, 2023QD Clinic – Recurrent Fevers; 3 Days at 103FMarch 02, 2023QD Clinic – Chest Pain & FeverFebruary 21, 2023testingFebruary 10, 2023Topic Page: Load more Go to Top SOLVING STILL’S DISEASE Sign up TO THE NEW MONTHLY EMAIL Still’s Disease & Autoinflammatory Reader Type Rheumatologist Patient or Concerned Individual Media/Press Other Healthcare Professional Other Physician Pharmaceutical Industry or Biotech Individual Pharmacist Physician Assistant, Nurse Practitioner, Rheumatology Nurse Primary Physician Trainee (Fellow, Resident, Student) Monthly Topic Digests (Choose one or many) Autoinflammatory & Still's Disease (via StillsNow) Email address: Leave this field empty if you're human:
Genetic Testing for Autoinflammatory DiseaseSeptember 01, 2022Disease Activity Scoring in Adult-onset Still's diseaseAugust 30, 2022JAK Inhibitors in Difficult Still’s DiseaseAugust 05, 2022Not Still’s – Now What?July 29, 2022Best Labs for Still’s DiseaseJuly 27, 2022FDA Approves Canakinumab for Gout FlaresAugust 30, 2023Before You Know It (8.25.2023)August 24, 2023Mono- and Oligo- are Different (8.18.2023)August 18, 2023EULAR/ACR Guidance on Haemophagocytic Lymphohistiocytosis/Macrophage Activation SyndromeJuly 26, 2023ICYMI: LAVLI – A New Autoinflammatory DisorderJuly 06, 2023EULAR 2023 Notes from Milan (6.09.2023)June 09, 20232023 EULAR/PReS Recommendations on Still's diseaseJune 08, 2023Still's Disease Abstracts at EULAR 2023June 08, 2023EULAR 2023 Notes from MilanJune 08, 2023EULAR 2023 Day 4 RecapJune 05, 2023AOSD: Young vs. Elderly OnsetJune 01, 2023“You Can Have it All” (4.7.2023)April 07, 2023LAVLI – A New Autoinflammatory DisorderMarch 28, 2023QD Clinic – Recurrent Fevers; 3 Days at 103FMarch 02, 2023QD Clinic – Chest Pain & FeverFebruary 21, 2023testingFebruary 10, 2023Topic Page: Load more Go to Top SOLVING STILL’S DISEASE Sign up TO THE NEW MONTHLY EMAIL Still’s Disease & Autoinflammatory Reader Type Rheumatologist Patient or Concerned Individual Media/Press Other Healthcare Professional Other Physician Pharmaceutical Industry or Biotech Individual Pharmacist Physician Assistant, Nurse Practitioner, Rheumatology Nurse Primary Physician Trainee (Fellow, Resident, Student) Monthly Topic Digests (Choose one or many) Autoinflammatory & Still's Disease (via StillsNow) Email address: Leave this field empty if you're human:
Disease Activity Scoring in Adult-onset Still's diseaseAugust 30, 2022JAK Inhibitors in Difficult Still’s DiseaseAugust 05, 2022Not Still’s – Now What?July 29, 2022Best Labs for Still’s DiseaseJuly 27, 2022FDA Approves Canakinumab for Gout FlaresAugust 30, 2023Before You Know It (8.25.2023)August 24, 2023Mono- and Oligo- are Different (8.18.2023)August 18, 2023EULAR/ACR Guidance on Haemophagocytic Lymphohistiocytosis/Macrophage Activation SyndromeJuly 26, 2023ICYMI: LAVLI – A New Autoinflammatory DisorderJuly 06, 2023EULAR 2023 Notes from Milan (6.09.2023)June 09, 20232023 EULAR/PReS Recommendations on Still's diseaseJune 08, 2023Still's Disease Abstracts at EULAR 2023June 08, 2023EULAR 2023 Notes from MilanJune 08, 2023EULAR 2023 Day 4 RecapJune 05, 2023AOSD: Young vs. Elderly OnsetJune 01, 2023“You Can Have it All” (4.7.2023)April 07, 2023LAVLI – A New Autoinflammatory DisorderMarch 28, 2023QD Clinic – Recurrent Fevers; 3 Days at 103FMarch 02, 2023QD Clinic – Chest Pain & FeverFebruary 21, 2023testingFebruary 10, 2023Topic Page: Load more Go to Top SOLVING STILL’S DISEASE Sign up TO THE NEW MONTHLY EMAIL Still’s Disease & Autoinflammatory Reader Type Rheumatologist Patient or Concerned Individual Media/Press Other Healthcare Professional Other Physician Pharmaceutical Industry or Biotech Individual Pharmacist Physician Assistant, Nurse Practitioner, Rheumatology Nurse Primary Physician Trainee (Fellow, Resident, Student) Monthly Topic Digests (Choose one or many) Autoinflammatory & Still's Disease (via StillsNow) Email address: Leave this field empty if you're human:
JAK Inhibitors in Difficult Still’s DiseaseAugust 05, 2022Not Still’s – Now What?July 29, 2022Best Labs for Still’s DiseaseJuly 27, 2022FDA Approves Canakinumab for Gout FlaresAugust 30, 2023Before You Know It (8.25.2023)August 24, 2023Mono- and Oligo- are Different (8.18.2023)August 18, 2023EULAR/ACR Guidance on Haemophagocytic Lymphohistiocytosis/Macrophage Activation SyndromeJuly 26, 2023ICYMI: LAVLI – A New Autoinflammatory DisorderJuly 06, 2023EULAR 2023 Notes from Milan (6.09.2023)June 09, 20232023 EULAR/PReS Recommendations on Still's diseaseJune 08, 2023Still's Disease Abstracts at EULAR 2023June 08, 2023EULAR 2023 Notes from MilanJune 08, 2023EULAR 2023 Day 4 RecapJune 05, 2023AOSD: Young vs. Elderly OnsetJune 01, 2023“You Can Have it All” (4.7.2023)April 07, 2023LAVLI – A New Autoinflammatory DisorderMarch 28, 2023QD Clinic – Recurrent Fevers; 3 Days at 103FMarch 02, 2023QD Clinic – Chest Pain & FeverFebruary 21, 2023testingFebruary 10, 2023Topic Page: Load more Go to Top SOLVING STILL’S DISEASE Sign up TO THE NEW MONTHLY EMAIL Still’s Disease & Autoinflammatory Reader Type Rheumatologist Patient or Concerned Individual Media/Press Other Healthcare Professional Other Physician Pharmaceutical Industry or Biotech Individual Pharmacist Physician Assistant, Nurse Practitioner, Rheumatology Nurse Primary Physician Trainee (Fellow, Resident, Student) Monthly Topic Digests (Choose one or many) Autoinflammatory & Still's Disease (via StillsNow) Email address: Leave this field empty if you're human:
Not Still’s – Now What?July 29, 2022Best Labs for Still’s DiseaseJuly 27, 2022FDA Approves Canakinumab for Gout FlaresAugust 30, 2023Before You Know It (8.25.2023)August 24, 2023Mono- and Oligo- are Different (8.18.2023)August 18, 2023EULAR/ACR Guidance on Haemophagocytic Lymphohistiocytosis/Macrophage Activation SyndromeJuly 26, 2023ICYMI: LAVLI – A New Autoinflammatory DisorderJuly 06, 2023EULAR 2023 Notes from Milan (6.09.2023)June 09, 20232023 EULAR/PReS Recommendations on Still's diseaseJune 08, 2023Still's Disease Abstracts at EULAR 2023June 08, 2023EULAR 2023 Notes from MilanJune 08, 2023EULAR 2023 Day 4 RecapJune 05, 2023AOSD: Young vs. Elderly OnsetJune 01, 2023“You Can Have it All” (4.7.2023)April 07, 2023LAVLI – A New Autoinflammatory DisorderMarch 28, 2023QD Clinic – Recurrent Fevers; 3 Days at 103FMarch 02, 2023QD Clinic – Chest Pain & FeverFebruary 21, 2023testingFebruary 10, 2023Topic Page: Load more Go to Top SOLVING STILL’S DISEASE Sign up TO THE NEW MONTHLY EMAIL Still’s Disease & Autoinflammatory Reader Type Rheumatologist Patient or Concerned Individual Media/Press Other Healthcare Professional Other Physician Pharmaceutical Industry or Biotech Individual Pharmacist Physician Assistant, Nurse Practitioner, Rheumatology Nurse Primary Physician Trainee (Fellow, Resident, Student) Monthly Topic Digests (Choose one or many) Autoinflammatory & Still's Disease (via StillsNow) Email address: Leave this field empty if you're human:
Best Labs for Still’s DiseaseJuly 27, 2022FDA Approves Canakinumab for Gout FlaresAugust 30, 2023Before You Know It (8.25.2023)August 24, 2023Mono- and Oligo- are Different (8.18.2023)August 18, 2023EULAR/ACR Guidance on Haemophagocytic Lymphohistiocytosis/Macrophage Activation SyndromeJuly 26, 2023ICYMI: LAVLI – A New Autoinflammatory DisorderJuly 06, 2023EULAR 2023 Notes from Milan (6.09.2023)June 09, 20232023 EULAR/PReS Recommendations on Still's diseaseJune 08, 2023Still's Disease Abstracts at EULAR 2023June 08, 2023EULAR 2023 Notes from MilanJune 08, 2023EULAR 2023 Day 4 RecapJune 05, 2023AOSD: Young vs. Elderly OnsetJune 01, 2023“You Can Have it All” (4.7.2023)April 07, 2023LAVLI – A New Autoinflammatory DisorderMarch 28, 2023QD Clinic – Recurrent Fevers; 3 Days at 103FMarch 02, 2023QD Clinic – Chest Pain & FeverFebruary 21, 2023testingFebruary 10, 2023Topic Page: Load more Go to Top SOLVING STILL’S DISEASE Sign up TO THE NEW MONTHLY EMAIL Still’s Disease & Autoinflammatory Reader Type Rheumatologist Patient or Concerned Individual Media/Press Other Healthcare Professional Other Physician Pharmaceutical Industry or Biotech Individual Pharmacist Physician Assistant, Nurse Practitioner, Rheumatology Nurse Primary Physician Trainee (Fellow, Resident, Student) Monthly Topic Digests (Choose one or many) Autoinflammatory & Still's Disease (via StillsNow) Email address: Leave this field empty if you're human:
FDA Approves Canakinumab for Gout FlaresAugust 30, 2023Before You Know It (8.25.2023)August 24, 2023Mono- and Oligo- are Different (8.18.2023)August 18, 2023EULAR/ACR Guidance on Haemophagocytic Lymphohistiocytosis/Macrophage Activation SyndromeJuly 26, 2023ICYMI: LAVLI – A New Autoinflammatory DisorderJuly 06, 2023EULAR 2023 Notes from Milan (6.09.2023)June 09, 20232023 EULAR/PReS Recommendations on Still's diseaseJune 08, 2023Still's Disease Abstracts at EULAR 2023June 08, 2023EULAR 2023 Notes from MilanJune 08, 2023EULAR 2023 Day 4 RecapJune 05, 2023AOSD: Young vs. Elderly OnsetJune 01, 2023“You Can Have it All” (4.7.2023)April 07, 2023LAVLI – A New Autoinflammatory DisorderMarch 28, 2023QD Clinic – Recurrent Fevers; 3 Days at 103FMarch 02, 2023QD Clinic – Chest Pain & FeverFebruary 21, 2023testingFebruary 10, 2023Topic Page: Load more Go to Top SOLVING STILL’S DISEASE Sign up TO THE NEW MONTHLY EMAIL Still’s Disease & Autoinflammatory Reader Type Rheumatologist Patient or Concerned Individual Media/Press Other Healthcare Professional Other Physician Pharmaceutical Industry or Biotech Individual Pharmacist Physician Assistant, Nurse Practitioner, Rheumatology Nurse Primary Physician Trainee (Fellow, Resident, Student) Monthly Topic Digests (Choose one or many) Autoinflammatory & Still's Disease (via StillsNow) Email address: Leave this field empty if you're human:
Before You Know It (8.25.2023)August 24, 2023Mono- and Oligo- are Different (8.18.2023)August 18, 2023EULAR/ACR Guidance on Haemophagocytic Lymphohistiocytosis/Macrophage Activation SyndromeJuly 26, 2023ICYMI: LAVLI – A New Autoinflammatory DisorderJuly 06, 2023EULAR 2023 Notes from Milan (6.09.2023)June 09, 20232023 EULAR/PReS Recommendations on Still's diseaseJune 08, 2023Still's Disease Abstracts at EULAR 2023June 08, 2023EULAR 2023 Notes from MilanJune 08, 2023EULAR 2023 Day 4 RecapJune 05, 2023AOSD: Young vs. Elderly OnsetJune 01, 2023“You Can Have it All” (4.7.2023)April 07, 2023LAVLI – A New Autoinflammatory DisorderMarch 28, 2023QD Clinic – Recurrent Fevers; 3 Days at 103FMarch 02, 2023QD Clinic – Chest Pain & FeverFebruary 21, 2023testingFebruary 10, 2023Topic Page: Load more Go to Top SOLVING STILL’S DISEASE Sign up TO THE NEW MONTHLY EMAIL Still’s Disease & Autoinflammatory Reader Type Rheumatologist Patient or Concerned Individual Media/Press Other Healthcare Professional Other Physician Pharmaceutical Industry or Biotech Individual Pharmacist Physician Assistant, Nurse Practitioner, Rheumatology Nurse Primary Physician Trainee (Fellow, Resident, Student) Monthly Topic Digests (Choose one or many) Autoinflammatory & Still's Disease (via StillsNow) Email address: Leave this field empty if you're human:
Mono- and Oligo- are Different (8.18.2023)August 18, 2023EULAR/ACR Guidance on Haemophagocytic Lymphohistiocytosis/Macrophage Activation SyndromeJuly 26, 2023ICYMI: LAVLI – A New Autoinflammatory DisorderJuly 06, 2023EULAR 2023 Notes from Milan (6.09.2023)June 09, 20232023 EULAR/PReS Recommendations on Still's diseaseJune 08, 2023Still's Disease Abstracts at EULAR 2023June 08, 2023EULAR 2023 Notes from MilanJune 08, 2023EULAR 2023 Day 4 RecapJune 05, 2023AOSD: Young vs. Elderly OnsetJune 01, 2023“You Can Have it All” (4.7.2023)April 07, 2023LAVLI – A New Autoinflammatory DisorderMarch 28, 2023QD Clinic – Recurrent Fevers; 3 Days at 103FMarch 02, 2023QD Clinic – Chest Pain & FeverFebruary 21, 2023testingFebruary 10, 2023Topic Page: Load more Go to Top SOLVING STILL’S DISEASE Sign up TO THE NEW MONTHLY EMAIL Still’s Disease & Autoinflammatory Reader Type Rheumatologist Patient or Concerned Individual Media/Press Other Healthcare Professional Other Physician Pharmaceutical Industry or Biotech Individual Pharmacist Physician Assistant, Nurse Practitioner, Rheumatology Nurse Primary Physician Trainee (Fellow, Resident, Student) Monthly Topic Digests (Choose one or many) Autoinflammatory & Still's Disease (via StillsNow) Email address: Leave this field empty if you're human:
EULAR/ACR Guidance on Haemophagocytic Lymphohistiocytosis/Macrophage Activation SyndromeJuly 26, 2023ICYMI: LAVLI – A New Autoinflammatory DisorderJuly 06, 2023EULAR 2023 Notes from Milan (6.09.2023)June 09, 20232023 EULAR/PReS Recommendations on Still's diseaseJune 08, 2023Still's Disease Abstracts at EULAR 2023June 08, 2023EULAR 2023 Notes from MilanJune 08, 2023EULAR 2023 Day 4 RecapJune 05, 2023AOSD: Young vs. Elderly OnsetJune 01, 2023“You Can Have it All” (4.7.2023)April 07, 2023LAVLI – A New Autoinflammatory DisorderMarch 28, 2023QD Clinic – Recurrent Fevers; 3 Days at 103FMarch 02, 2023QD Clinic – Chest Pain & FeverFebruary 21, 2023testingFebruary 10, 2023Topic Page: Load more Go to Top SOLVING STILL’S DISEASE Sign up TO THE NEW MONTHLY EMAIL Still’s Disease & Autoinflammatory Reader Type Rheumatologist Patient or Concerned Individual Media/Press Other Healthcare Professional Other Physician Pharmaceutical Industry or Biotech Individual Pharmacist Physician Assistant, Nurse Practitioner, Rheumatology Nurse Primary Physician Trainee (Fellow, Resident, Student) Monthly Topic Digests (Choose one or many) Autoinflammatory & Still's Disease (via StillsNow) Email address: Leave this field empty if you're human:
ICYMI: LAVLI – A New Autoinflammatory DisorderJuly 06, 2023EULAR 2023 Notes from Milan (6.09.2023)June 09, 20232023 EULAR/PReS Recommendations on Still's diseaseJune 08, 2023Still's Disease Abstracts at EULAR 2023June 08, 2023EULAR 2023 Notes from MilanJune 08, 2023EULAR 2023 Day 4 RecapJune 05, 2023AOSD: Young vs. Elderly OnsetJune 01, 2023“You Can Have it All” (4.7.2023)April 07, 2023LAVLI – A New Autoinflammatory DisorderMarch 28, 2023QD Clinic – Recurrent Fevers; 3 Days at 103FMarch 02, 2023QD Clinic – Chest Pain & FeverFebruary 21, 2023testingFebruary 10, 2023Topic Page: Load more Go to Top SOLVING STILL’S DISEASE Sign up TO THE NEW MONTHLY EMAIL Still’s Disease & Autoinflammatory Reader Type Rheumatologist Patient or Concerned Individual Media/Press Other Healthcare Professional Other Physician Pharmaceutical Industry or Biotech Individual Pharmacist Physician Assistant, Nurse Practitioner, Rheumatology Nurse Primary Physician Trainee (Fellow, Resident, Student) Monthly Topic Digests (Choose one or many) Autoinflammatory & Still's Disease (via StillsNow) Email address: Leave this field empty if you're human:
EULAR 2023 Notes from Milan (6.09.2023)June 09, 20232023 EULAR/PReS Recommendations on Still's diseaseJune 08, 2023Still's Disease Abstracts at EULAR 2023June 08, 2023EULAR 2023 Notes from MilanJune 08, 2023EULAR 2023 Day 4 RecapJune 05, 2023AOSD: Young vs. Elderly OnsetJune 01, 2023“You Can Have it All” (4.7.2023)April 07, 2023LAVLI – A New Autoinflammatory DisorderMarch 28, 2023QD Clinic – Recurrent Fevers; 3 Days at 103FMarch 02, 2023QD Clinic – Chest Pain & FeverFebruary 21, 2023testingFebruary 10, 2023Topic Page: Load more Go to Top SOLVING STILL’S DISEASE Sign up TO THE NEW MONTHLY EMAIL Still’s Disease & Autoinflammatory Reader Type Rheumatologist Patient or Concerned Individual Media/Press Other Healthcare Professional Other Physician Pharmaceutical Industry or Biotech Individual Pharmacist Physician Assistant, Nurse Practitioner, Rheumatology Nurse Primary Physician Trainee (Fellow, Resident, Student) Monthly Topic Digests (Choose one or many) Autoinflammatory & Still's Disease (via StillsNow) Email address: Leave this field empty if you're human:
2023 EULAR/PReS Recommendations on Still's diseaseJune 08, 2023Still's Disease Abstracts at EULAR 2023June 08, 2023EULAR 2023 Notes from MilanJune 08, 2023EULAR 2023 Day 4 RecapJune 05, 2023AOSD: Young vs. Elderly OnsetJune 01, 2023“You Can Have it All” (4.7.2023)April 07, 2023LAVLI – A New Autoinflammatory DisorderMarch 28, 2023QD Clinic – Recurrent Fevers; 3 Days at 103FMarch 02, 2023QD Clinic – Chest Pain & FeverFebruary 21, 2023testingFebruary 10, 2023Topic Page: Load more Go to Top SOLVING STILL’S DISEASE Sign up TO THE NEW MONTHLY EMAIL Still’s Disease & Autoinflammatory Reader Type Rheumatologist Patient or Concerned Individual Media/Press Other Healthcare Professional Other Physician Pharmaceutical Industry or Biotech Individual Pharmacist Physician Assistant, Nurse Practitioner, Rheumatology Nurse Primary Physician Trainee (Fellow, Resident, Student) Monthly Topic Digests (Choose one or many) Autoinflammatory & Still's Disease (via StillsNow) Email address: Leave this field empty if you're human:
Still's Disease Abstracts at EULAR 2023June 08, 2023EULAR 2023 Notes from MilanJune 08, 2023EULAR 2023 Day 4 RecapJune 05, 2023AOSD: Young vs. Elderly OnsetJune 01, 2023“You Can Have it All” (4.7.2023)April 07, 2023LAVLI – A New Autoinflammatory DisorderMarch 28, 2023QD Clinic – Recurrent Fevers; 3 Days at 103FMarch 02, 2023QD Clinic – Chest Pain & FeverFebruary 21, 2023testingFebruary 10, 2023Topic Page: Load more Go to Top SOLVING STILL’S DISEASE Sign up TO THE NEW MONTHLY EMAIL Still’s Disease & Autoinflammatory Reader Type Rheumatologist Patient or Concerned Individual Media/Press Other Healthcare Professional Other Physician Pharmaceutical Industry or Biotech Individual Pharmacist Physician Assistant, Nurse Practitioner, Rheumatology Nurse Primary Physician Trainee (Fellow, Resident, Student) Monthly Topic Digests (Choose one or many) Autoinflammatory & Still's Disease (via StillsNow) Email address: Leave this field empty if you're human:
EULAR 2023 Notes from MilanJune 08, 2023EULAR 2023 Day 4 RecapJune 05, 2023AOSD: Young vs. Elderly OnsetJune 01, 2023“You Can Have it All” (4.7.2023)April 07, 2023LAVLI – A New Autoinflammatory DisorderMarch 28, 2023QD Clinic – Recurrent Fevers; 3 Days at 103FMarch 02, 2023QD Clinic – Chest Pain & FeverFebruary 21, 2023testingFebruary 10, 2023Topic Page: Load more Go to Top SOLVING STILL’S DISEASE Sign up TO THE NEW MONTHLY EMAIL Still’s Disease & Autoinflammatory Reader Type Rheumatologist Patient or Concerned Individual Media/Press Other Healthcare Professional Other Physician Pharmaceutical Industry or Biotech Individual Pharmacist Physician Assistant, Nurse Practitioner, Rheumatology Nurse Primary Physician Trainee (Fellow, Resident, Student) Monthly Topic Digests (Choose one or many) Autoinflammatory & Still's Disease (via StillsNow) Email address: Leave this field empty if you're human:
EULAR 2023 Day 4 RecapJune 05, 2023AOSD: Young vs. Elderly OnsetJune 01, 2023“You Can Have it All” (4.7.2023)April 07, 2023LAVLI – A New Autoinflammatory DisorderMarch 28, 2023QD Clinic – Recurrent Fevers; 3 Days at 103FMarch 02, 2023QD Clinic – Chest Pain & FeverFebruary 21, 2023testingFebruary 10, 2023Topic Page: Load more Go to Top SOLVING STILL’S DISEASE Sign up TO THE NEW MONTHLY EMAIL Still’s Disease & Autoinflammatory Reader Type Rheumatologist Patient or Concerned Individual Media/Press Other Healthcare Professional Other Physician Pharmaceutical Industry or Biotech Individual Pharmacist Physician Assistant, Nurse Practitioner, Rheumatology Nurse Primary Physician Trainee (Fellow, Resident, Student) Monthly Topic Digests (Choose one or many) Autoinflammatory & Still's Disease (via StillsNow) Email address: Leave this field empty if you're human:
AOSD: Young vs. Elderly OnsetJune 01, 2023“You Can Have it All” (4.7.2023)April 07, 2023LAVLI – A New Autoinflammatory DisorderMarch 28, 2023QD Clinic – Recurrent Fevers; 3 Days at 103FMarch 02, 2023QD Clinic – Chest Pain & FeverFebruary 21, 2023testingFebruary 10, 2023Topic Page: Load more Go to Top SOLVING STILL’S DISEASE Sign up TO THE NEW MONTHLY EMAIL Still’s Disease & Autoinflammatory Reader Type Rheumatologist Patient or Concerned Individual Media/Press Other Healthcare Professional Other Physician Pharmaceutical Industry or Biotech Individual Pharmacist Physician Assistant, Nurse Practitioner, Rheumatology Nurse Primary Physician Trainee (Fellow, Resident, Student) Monthly Topic Digests (Choose one or many) Autoinflammatory & Still's Disease (via StillsNow) Email address: Leave this field empty if you're human:
“You Can Have it All” (4.7.2023)April 07, 2023LAVLI – A New Autoinflammatory DisorderMarch 28, 2023QD Clinic – Recurrent Fevers; 3 Days at 103FMarch 02, 2023QD Clinic – Chest Pain & FeverFebruary 21, 2023testingFebruary 10, 2023Topic Page: Load more Go to Top
LAVLI – A New Autoinflammatory DisorderMarch 28, 2023QD Clinic – Recurrent Fevers; 3 Days at 103FMarch 02, 2023QD Clinic – Chest Pain & FeverFebruary 21, 2023testingFebruary 10, 2023Topic Page: Load more
QD Clinic – Recurrent Fevers; 3 Days at 103FMarch 02, 2023QD Clinic – Chest Pain & FeverFebruary 21, 2023testingFebruary 10, 2023Topic Page: Load more